Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Falanga

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Nanoscale Research Letters|February 9, 2018
Comparison Between Folic Acid and gH625 Peptide-Based Functionalization of Fe<sub>3</sub>O<sub>4</sub> Magnetic Nanoparticles for Enhanced Cell InternalizationC Tudisco, M T Cambria, A E Giuffrida, et al.
Journal of Thrombosis and Haemostasis : JTH|July 26, 2012
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent resultsV Pengo, L Crippa, A Falanga, et al.
Pediatric Transplantation|March 21, 2012
The impact of perioperative transfusion of blood products on survival after pediatric liver transplantationM Nacoti, S Cazzaniga, F Lorusso, et al.
Thrombosis Research|May 11, 2016
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational statusA Vignoli, S Tessarolo, M Marchetti, et al.
Orphanet Journal of Rare Diseases|June 23, 2022
Lombardy diagnostic and therapeutic network of thrombotic microangiopathyI Mancini, P Agosti, M Boscarino, et al.
Journal of Thrombosis and Haemostasis : JTH|July 6, 2010
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant gliomaJ R Perry, J A Julian, N J Laperriere, et al.
Frontiers in Cardiovascular Medicine|December 15, 2023
Clinical variables associated with late-onset thrombotic and cardiovascular events, after SARS-CoV-2 infection, in a cohort of patients from the first epidemic wave: an 18-month analysis on the "Surviving-COVID" cohort from Bergamo, ItalyS V Benatti, S Venturelli, G Crotti, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2017
External validation of the DASH prediction rule: a retrospective cohort studyA Tosetto, S Testa, I Martinelli, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2015
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosisS Schulman, M Zondag, L Linkins, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2012
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerD Farge, P Debourdeau, M Beckers, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Nanoscale Research Letters|February 9, 2018
Comparison Between Folic Acid and gH625 Peptide-Based Functionalization of Fe<sub>3</sub>O<sub>4</sub> Magnetic Nanoparticles for Enhanced Cell InternalizationC Tudisco, M T Cambria, A E Giuffrida, et al.
Journal of Thrombosis and Haemostasis : JTH|July 26, 2012
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent resultsV Pengo, L Crippa, A Falanga, et al.
Pediatric Transplantation|March 21, 2012
The impact of perioperative transfusion of blood products on survival after pediatric liver transplantationM Nacoti, S Cazzaniga, F Lorusso, et al.
Thrombosis Research|May 11, 2016
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational statusA Vignoli, S Tessarolo, M Marchetti, et al.
Orphanet Journal of Rare Diseases|June 23, 2022
Lombardy diagnostic and therapeutic network of thrombotic microangiopathyI Mancini, P Agosti, M Boscarino, et al.
Journal of Thrombosis and Haemostasis : JTH|July 6, 2010
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant gliomaJ R Perry, J A Julian, N J Laperriere, et al.
Frontiers in Cardiovascular Medicine|December 15, 2023
Clinical variables associated with late-onset thrombotic and cardiovascular events, after SARS-CoV-2 infection, in a cohort of patients from the first epidemic wave: an 18-month analysis on the "Surviving-COVID" cohort from Bergamo, ItalyS V Benatti, S Venturelli, G Crotti, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2017
External validation of the DASH prediction rule: a retrospective cohort studyA Tosetto, S Testa, I Martinelli, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2015
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosisS Schulman, M Zondag, L Linkins, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2012
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerD Farge, P Debourdeau, M Beckers, et al.
Pageof 9